Adage Capital Partners Gp, L.L.C. Alector, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$10.54 - $24.96 $3.16 Million - $7.49 Million	-300,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$21.87 - $33.11 $2.19 Million - $3.31 Million	-100,000 Reduced 25.0%	300,000 $7.33 Million
Q1 2020 May 15, 2020	BUY	$16.25 - $35.28 $3.66 Million - $7.94 Million	225,000 Added 128.57%	400,000 $9.65 Million
Q3 2019 Nov 14, 2019	BUY	$14.42 - $22.2 $2.52 Million - $3.89 Million	175,000 New	175,000 $2.52 Million

168

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $214M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.